GR-2202

N/A

Report date: 2025/02/17 14:16:56

Base Information

Drug NameGR-2202
Drug Alias NameGR-2202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsPsoriasisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChongqing Genrix Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Genrix Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A